1-4 of 4
Shanhao Tang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Prospective, Multicenter, Single-Arm Study on the Combination of Orelabrutinib and Rituximab in the Second-Line Treatment of Relapsed/Refractory Marginal Zone Lymphoma

Guifang Ouyang, Lixia Sheng, Jiaping Wang, Hui Zeng, Shanhao Tang, Xibin Xiao, Yamin Tan, Qunyi Guo, Yanping Shao, Minchao Yan, Wenbin Qian
Journal: Blood
Blood (2024) 144 (Supplement 1): 4391.
https://doi.org/10.1182/blood-2024-198485
Published: 2024
Journal Articles

Preliminary Data on the Efficacy and Safety of Orelabrutinib Combined with Rituximab and Methotrexate (ORM Regimen) As First-Line Treatment for Primary Central Nervous System Lymphoma, and the Exploration of Cerebrospinal Fluid Ctdna Dynamic Monitoring

Lixia Sheng, Guifang Ouyang, Yanli Lai, Sheng Nie, Di Wang, Shanhao Tang, Yuning Pan, Kaihong Xu, Yongcheng Sun, Ping Zhang, Binbin Lai, Lieguang Chen
Journal: Blood
Blood (2024) 144 (Supplement 1): 4500.
https://doi.org/10.1182/blood-2024-198355
Published: 2024
Journal Articles

Ikaros Family Zinc Finger 1 Mutation Is a Poor Prognosis Factor of Adult B Cell Acute Lymphoblastic Leukemia

Shanhao Tang, Hongjie Shen, Xinliang Mao, MD PhD, Haiping Dai, Xiaming Zhu, Shengli Xue, Zixuan Ding, Jing Lu, Depei Wu, MD, XiaoWen Tang, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5117.
https://doi.org/10.1182/blood.V130.Suppl_1.5117.5117
Published: 2017
Journal Articles

Prognostic Impact of FLT3-ITD and DNMT3A R882 Double Mutations in Patients with Acute Myeloid Leukemia

Shanhao Tang, Xiaowen Tang, MD, Hongjie Shen, Shengli Xue, Tingjing Wang, Jing Lu, Jia Yin, Depei Wu, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5244.
https://doi.org/10.1182/blood.V128.22.5244.5244
Published: 2016